Interestingly, previous studies have shown that this chemokine is not expressed in human or murine TNBC and that intratumoral delivery of CCL25 enhances anti-tumor effects by stimulating CCR9 + CD8 + T cell tumor infiltration [41]. This evidence concerns the gene CCR9 and neoplasm.